Picture of Viracta Therapeutics logo

VIRX — Viracta Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Viracta Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

* Viracta Therapeutics Inc  VIRX.OQ  reported a quarterly
adjusted
loss of 25 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of -32 cents.  The mean expectation of
three analysts for the quarter was for a loss of 37 cents per
share. Wall Street expected results to range from -40 cents
to -34 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Viracta Therapeutics Inc's reported EPS for the quarter
was a
loss of 25 cents​.
    * The company reported a quarterly loss of $9.83 million.
    * Viracta Therapeutics Inc shares had fallen by 14.4% this
quarter and lost 18.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 18.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Viracta
Therapeutics Inc is $5.00 
This summary was machine generated from LSEG data August 14 at
01:12 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.37          -0.25          Beat
 Mar. 31 2024      -0.35          -0.23          Beat
 Dec. 31 2023      -0.31          -0.35          Missed
 Sep. 30 2023      -0.30          -0.33          Missed

Recent news on Viracta Therapeutics

See all news